Advisory Services Network’s Vir Biotechnology VIR Stock Holding History

Advisory Services Network’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.25K	Buy	+139	New	+$1.11K	﹤0.01%	4269
2025 Q4	–	Sell	-139	Closed	-$794	–	4166
2025 Q3	$794	Buy	+139	New	+$711	﹤0.01%	3975
2024 Q1	–	Sell	-100	Closed	-$1.01K	–	3608
2023 Q4	$1.01K	Buy	+100	New	+$914	﹤0.01%	3532
2023 Q2	–	Sell	-50	Closed	-$1.16K	–	3601
2023 Q1	$1.16K	Buy	+50	New	+$1.28K	﹤0.01%	3585
2020 Q4	–	Sell	-343	Closed	-$12K	–	3757
2020 Q3	$12K	Buy	+343	New	+$14.8K	﹤0.01%	2358

Other funds holding VIR

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

GSK plc London $599M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return